Royal Bank of Canada’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
BCM
KAS
KOC
Royal Bank of Canada's CODX Position: Q3 2024 in Review
Royal Bank of Canada sold out of Co-Diagnostics (CODX) in Q3 2024, closing a stake of 7 shares.
Royal Bank of Canada first reported a position in CODX in Q1 2020 and held it in 17 quarters. The position peaked at $1.09M in Q3 2021. 36 funds tracked by Wall St. Rank hold CODX as of Q3 2024.
- Royal Bank of Canada reported no remaining Co-Diagnostics position as of Q3 2024 after selling out during the quarter.
- Royal Bank of Canada sold 7 Co-Diagnostics shares in Q3 2024.
- Royal Bank of Canada first reported a position in Co-Diagnostics in Q1 2020 and held it in 17 quarters.
- Royal Bank of Canada's Co-Diagnostics position peaked at $1.09M in Q3 2021.
- 36 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2024.
Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.